Patient Characteristics for RA Patients Who Were Treated With Sarilumab (Kevzara)

Grant

Date/time Interval

  • May 15, 2020 - May 14, 2022
  • Total Award Amount

  • 69960.00
  • Direct Costs

  • 64778.00
  • Sponsor Award Id

  • Contributor

  • Huifeng Yun Ph.D.   Principal Investigator  
  • Jeffrey Curtis MD, MS, MPH   Investigator